Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery

Haematologia

Volumn 30, Issue 3, 2000, Pages 193-201

  Tamir, L ^a   Fradin, Z ^a   Fridlander, M ^a   Ashkenazi, U ^a   Zeidman, A ^a   Cohen, A M ^a   Hendel, D ^a   Mittelman, M ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Blood transfusion requirement; Hip replacement; Knee replacement; Recombinant human erythropoietin

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ALLOGENEIC RESTRICTION; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HEMOGLOBIN DETERMINATION; HUMAN; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

EID: 0033670580     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: 10.1163/156855900300109198     Document Type: Article

References (37)

1. Carson, J. L., Poses, R. M., Spence, R. K., Bonovito, G., Severity of anemia and operative mortality and morbidity, Lancet 2, 727 (1988).
2. Spence, R. K., Carson, J. A., Poses, R. M., Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality, Amer. J. Surg. 159, 320 (1990).
3. Williamson, L., Homologous blood transfusion: the risk and alternatives, Br. J. Haematol. 88, 451 (1994).
4. Cazzola, M., Mercuriali, F., Brupnara, C., Use of recombinant human erythropoietin outside the setting of uremia, Blood 89, 4248 (1997).
5. Goodnough, L. T., Brecher, M. E., Kanter, M. H., AuBuchon, J. P., Transfusion medicine -blood transfusion, N. Engl. J. Med. 340, 438 (1999).
6. Spence, R. K., Emerging trends in surgical blood transfusion, Semin. Hematol. 34, 48 (1997).
7. Hedelstorm, M., Flordal, P. A., Tetal, D. H., Autologous blood transfusion in hip replacement. No effect on blood loss but less increase of plasminogen activator inhibitor in a randomized series of 80 patients, Acta Orthop. Scand. 67, 317 (1996).
8. Kunter, M. H., Maaren, D., Anders, K. H., Preoperative autologous blood donation before elective hysterectomy, J. Am. Med. Assoc. 276, 798 (1996).
9. Spivak, J. L., Pham, T., Isaacs, M., Hankins, D. W., Erythropoietin is both a mitogen and a survival factor, Blood 77, 1228 (1991).
10. Mittelman, M., Recombinant erythropoietin in myelodysplastic syndromes - whom to treat and how? more questions than answers, Acta Haematol. 90, 53 (1993).
11. Mittelman, M., Lessin, L. S., Clinical applications of recombinant erythropoietin in myelodysplasia, in: Hematology-Oncology Clinics of North America: Erythropoietin-Basic and Clinical Aspects, Spivak, J. L. (Ed.), pp. 993-1009. W. B. Saundes Company, Philadelphia (1994).
12. Eschbach, J. W., Kelly, M. R., Haley, N. R., Treatment of the anemia of progressive renal failure with recombinant human erythropoietin, N. Engl. J. Med. 321, 158 (1989).
13. Spivak, J. L., Recombinant human erythropoietin and the anemia of cancer, Blood 84, 997 (1994).
14. Cazzola, M., Ponchio, L., Beguin, Y., Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of phase I\II clinical trial, Blood 79, 29 (1992).
15. Mittelman, M., Anemia of cancer: Pathogenesis and treatment with recombinant human erythropoietin, Isr. J. Med. Sci. 32, 1201 (1996).
16. Henry, D. H., Beall, G. N., Benson, C. A., Recombinant human erythropoietin in the treatment of anemia associated with human immunodefficiency virus (HIV) infection and zidovudine therapy, Ann. Intern. Med. 117, 739 (1992).
17. Schreiber, S., Howaldt, S., Schnoor, M., Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease, N. Engl. J. Med. 334, 619 (1996).
18. Goodnough, L. T., Rudnick, S., Price, T. H., Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy, N. Engl. J. Med. 321, 1163 (1989).
19. Adamson, J., Messner, K., Beris, P., Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery, Semin. Hematol. 33, 15 (1996).
20. Baudoux, E., Messner, K., Jeekel, J., Tryba, M., Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients, Semin. Hematol. 33, 31 (1996).
21. Mercuriali, F., Zanella, A., Barosi, G., Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients, Transfusion 33, 55 (1993).
22. Mercuriali, F., Messner, K., Beris, P., Epotin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery, Semin. Hematol. 33, 10 (1996).
23. Mercuriali, F., Inghilleri, G., Biffi, E., Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: A randomized, double-blind, placebo-controlled, dose-ranging study, Acta Haematol. 100, 69 (1998).
24. Biesma, D. H., Marx, J. J. M., Kraaijer Hapner, R. J., Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin, Lancet 334, 367 (1994).
25. Nydegger, U., Baudoux, E., Messner, K., Enhanced efficacy of autologous blood donation with Epoetin alfa, Semin. Hematol. 33, 39 (1996).
26. Baron, J. F., Messner, K., Beris, P., Autologous blood donation with recombinant human erythropoietin in cardiac surgery: The Japanese experience, Semin. Hematol. 33, 64 (1996).
27. Gombotz, H., Messner, K., Baron, J. F., Monk, T., Subcutaneous Epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery, Semin. Hematol. 33, 69 (1996).
28. Atabek, V., Alvarez, R., Pello, M. J., Erythropoietin accelerates hematocrit recovery in post surgical anemia, Am. Surg. 61, 74 (1995).
29. D'Ambra, M., Messner, K., Gombotz, H., Perioperative Epoetin alfa reduces transfusion requirements in coronary artery bypass graft surgery, Semin. Hematol. 33, 73 (1996).
30. Mercuriali, F., Inghilleri, G., Biffi, E., Colotti, M. T., Short term low dose recombinant human erythropoietin administration in surgery, Br. J. Anesthes. 78, 64 (1997).
31. Canadian Orthopedic Perioperative Study Group, Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement, Lancet 341, 1227 (1993).
32. Adamson, J., Messner, K., Monk, T., Perisurgical use of Epoetin alfa in orthopedic surgery patients, Semin. Hematol. 33, 55 (1996).
33. Faris, P. M., Ritter, M. A., Abels, R. I., The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopedic operation. The American Erythropoietin Study Group, J. Bone Joint Surg. Am. 78, 62 (1996).
34. deAndrade, J. R., Jove, M., Landon, G., Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients, Am. J. Orthoped. 25, 533 (1996).
35. Hays, M. B., May Field, J. F., Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations, J. Arthroplasty s47 (1988).
36. Goldberg, M. A., Perioperative Epoetin alfa increases red blood cell mass and reduces exposure to transfusions. Results of randomized clinical trials, Semin. Hematol. 34, 41 (1997).
37. Tryba, M., Messner, K, Mcclelland, B., Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery, Semin. Hematol. 33, 22 (1996).